Angeles Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,507
Closed -$438K 150
2024
Q4
$438K Sell
16,507
-340
-2% -$9.22K 0.02% 107
2024
Q3
$488K Hold
16,847
0.02% 104
2024
Q2
$471K Sell
16,847
-3,650
-18% -$100K 0.02% 110
2024
Q1
$569K Buy
20,497
+1,495
+8% +$41.5K 0.03% 93
2023
Q4
$547K Buy
19,002
+514
+3% +$15.5K 0.03% 86
2023
Q3
$613K Sell
18,488
-732
-4% -$25.9K 0.05% 59
2023
Q2
$705K Buy
19,220
+1,442
+8% +$56.1K 0.06% 43
2023
Q1
$725K Buy
17,778
+10,335
+139% +$446K 0.06% 36
2022
Q4
$381K Buy
+7,443
New +$357K 0.03% 51
2022
Q3
Sell
-6,680
Closed -$350K 98
2022
Q2
$350K Hold
6,680
0.03% 51
2022
Q1
$346K Sell
6,680
-9,706
-59% -$504K 0.02% 76
2021
Q4
$968K Buy
16,386
+5,160
+46% +$256K 0.05% 81
2021
Q3
$483K Buy
+11,226
New +$497K 0.03% 110
2020
Q3
Sell
-8,118
Closed -$252K 115
2020
Q2
$252K Buy
+8,118
New +$276K 0.04% 91
2020
Q1
Sell
-6,209
Closed -$231K 101
2019
Q4
$231K Hold
6,209
0.05% 78
2019
Q3
$212K Buy
+6,209
New +$226K 0.05% 73

Other funds holding PFE

Angeles Investment Advisors's PFE Position: Q1 2025 in Review

Angeles Investment Advisors sold out of Pfizer (PFE) in Q1 2025, closing a stake of 16,507 shares — an estimated $438K sold.

Angeles Investment Advisors first reported a position in PFE in Q3 2019 and held it in 16 quarters. The position peaked at $968K in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Angeles Investment Advisors reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Angeles Investment Advisors sold 16,507 Pfizer shares in Q1 2025, an estimated $438K.
  • Angeles Investment Advisors first reported a position in Pfizer in Q3 2019 and held it in 16 quarters.
  • Angeles Investment Advisors's Pfizer position peaked at $968K in Q4 2021.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Angeles Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.